David Bom
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Catalytic C–H Functionalization Methods
Papers in
-
- Cancer therapeutics and mechanisms 11
- DNA and Nucleic Acid Chemistry 2
- Oncology 5
- Neutropenia and Cancer Infections 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Dennis P. Curran (9 shared papers)David A. Jacques (1 shared paper)Mark S. Meier (1 shared paper)John P. Selegue (1 shared paper)Rodney Andrews (1 shared paper)John E. Anthony (1 shared paper)Bailin Chen (1 shared paper)Thomas G. Burke (7 shared papers)
- Journals
- Annals of the New York Academy of Sciences (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Nano Letters (1 paper)Journal of Agricultural and Food Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
David Bom
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Toxicology 131
- Organic Chemistry 284
- Oncology 224
- Molecular Biology 492
- Materials Chemistry 341
Countries citing papers authored by David Bom
This map shows the geographic impact of David Bom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bom more than expected).
Fields of papers citing papers by David Bom
This network shows the impact of papers produced by David Bom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bom. The network helps show where David Bom may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 449 | |
| 2 | 2000 | 142 | |
| 3 | 1998 | 132 | |
| 4 | 2004 | 70 | |
| 5 | 1999 | 68 | |
| 6 | 1997 | 53 | |
| 7 | Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo. | 1999 | 52 |
| 8 | 2001 | 47 | |
| 9 | 2002 | 43 | |
| 10 | 2000 | 35 | |
| 11 | 2012 | 34 | |
| 12 | 2000 | 20 | |
| 13 | Affinity of new anticancer agent, DB-174, to membranes and HSA determined by fluorescence spectroscopy methods | 2006 | 2 |
| 14 | 2000 | 2 | |
| 15 | 1998 | 2 |
About David Bom
David Bom is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Neurology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Neutropenia and Cancer Infections (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Fluorine in Organic Chemistry (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Cancer Treatment and Pharmacology (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Toxicology (131 citations), Organic Chemistry (284 citations), Oncology (224 citations), Molecular Biology (492 citations) and Materials Chemistry (341 citations). David Bom has collaborated with scholars based in United States. Frequent co-authors include Dennis P. Curran, David A. Jacques, Mark S. Meier, John P. Selegue, Rodney Andrews, John E. Anthony, Bailin Chen, Thomas G. Burke, Hubert Josien and Sung‐Bo Ko. Their work appears in journals such as Annals of the New York Academy of Sciences, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Nano Letters and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.